K-numberK250341
Device nameSensilift Pro (ST300XXYYZZZ)
ApplicantEl Global Trade, Ltd.
Product codePAY
Device classClass II
Decision dateJan 6, 2026
DecisionSubstantially Equivalent
Regulation878.4420
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Sensilift Pro is an over-the-counter, home-use radiofrequency (RF) device designed for non-invasive treatment of mild to moderate facial wrinkles in adults with Fitzpatrick skin types I–IV. The hand-held device emits 1 MHz RF energy to heat facial tissue, with a maximum temperature limit of 40±0.5°C and maximum power output of 6±1 Watt. Treatment involves 5 minutes per area, once weekly for 8 consecutive weeks.

Technological characteristics

The device operates at 1 MHz RF frequency (bi-polar configuration) with 2 electrodes, 176 mm² treatment area per electrode, 3 user-selectable energy levels (3.5, 5, and 6 Watts), dual redundant thermistors for temperature control, rechargeable battery, and compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, and IEC 60601-2-2 safety standards. It differs from Sensilift (predicate 1) in cordless design and from Pollogen STOP U (predicate 2) in having 2 electrodes versus 4, and 3 energy levels versus 2.

Test standards cited

IEC 60601-1:2005/2024; IEC 60601-1-2:2014; IEC 60601-1-11:2015; IEC 60601-2-2:2017; ISO 10993-1:2018, ISO 10993-5:2009, ISO 10993-10:2021 (biocompatibility); FDA guidance on software V&V (Basic level) and cybersecurity risk management (Low overall risk).

Substantial equivalence argument

Sensilift Pro is substantially equivalent to predicate devices because it shares identical regulatory classification (Class II, PAY, 21 CFR 878.4420), intended use (OTC home-use RF wrinkle reduction for Fitzpatrick I–IV), anatomical sites, treatment regimen, energy source (1 MHz RF), body-contact materials (ABS plastic, chrome electrodes), and safety standards compliance. Minor differences in handpiece size, weight, LED indicators, and cordless operation do not raise new safety or effectiveness concerns and are supported by equivalent performance testing including electrical safety, EMC, software validation, and human factors studies.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →